tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

EuroEyes Reports Growth in Eye Surgeries for Q3 2025

Story Highlights
EuroEyes Reports Growth in Eye Surgeries for Q3 2025

TipRanks Cyber Monday Sale

EuroEyes International Eye Clinic Limited ( (HK:1846) ) just unveiled an update.

EuroEyes International Eye Clinic Limited reported a 5.6% increase in the total number of eye surgeries for the third quarter of 2025 compared to the same period in 2024, driven by a rise in lens exchange surgeries and a recovery in laser surgery volume. This growth indicates a positive trend in patient demand, enhancing the company’s performance and providing stakeholders with more comprehensive insights into its operational success.

The most recent analyst rating on (HK:1846) stock is a Hold with a HK$3.50 price target. To see the full list of analyst forecasts on EuroEyes International Eye Clinic Limited stock, see the HK:1846 Stock Forecast page.

More about EuroEyes International Eye Clinic Limited

EuroEyes International Eye Clinic Limited operates in the healthcare industry, specializing in eye surgeries. The company focuses on procedures such as lens exchange and laser surgeries, catering to a growing patient demand.

Average Trading Volume: 194,654

Technical Sentiment Signal: Sell

Current Market Cap: HK$1.02B

See more insights into 1846 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1